|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:drug
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:CASNumber
|
21519-46-8
|
|
gptkbp:chemicalFormula
|
C17H18ClNO
|
|
gptkbp:developedBy
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:discoveredBy
|
1970s
|
|
gptkbp:drugClass
|
antidepressant
|
|
gptkbp:hasInChIKey
|
QKJXYYOQSYFJNP-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
COC1=CC=CC=C1OCC2=CC=CC=C2N
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Nisoxetine
|
|
gptkbp:IUPACName
|
gptkb:(RS)-[2-(2-methoxyphenoxy)phenyl]methylamine_hydrochloride
|
|
gptkbp:legalStatus
|
not approved for medical use
|
|
gptkbp:mechanismOfAction
|
selective norepinephrine reuptake inhibitor
|
|
gptkbp:molecularWeight
|
287.79 g/mol
|
|
gptkbp:not_marketed_as
|
antidepressant
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL21108
4496
|
|
gptkbp:relatedTo
|
gptkb:atomoxetine
gptkb:reboxetine
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:studiedBy
|
gptkb:depression
gptkb:attention_deficit_hyperactivity_disorder
|
|
gptkbp:synonym
|
gptkb:Nisoxytine
gptkb:LY94939
|
|
gptkbp:UNII
|
0V1QH5A8P9
|
|
gptkbp:bfsParent
|
gptkb:CHEMBL14237
gptkb:CHEMBL1201202
gptkb:CHEMBL14218
gptkb:CHEMBL1201310
gptkb:CHEMBL121412
gptkb:CHEMBL122931
gptkb:CHEMBL29997
gptkb:CHEMBL14267
gptkb:CHEMBL1201209
|
|
gptkbp:bfsLayer
|
7
|